These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9813322)

  • 1. Alterations in local cerebral glucose utilization produced by D3 dopamine receptor-selective doses of 7-OH-DPAT and nafadotride.
    Levant B; Cross RS; Pazdernik TL
    Brain Res; 1998 Nov; 812(1-2):193-9. PubMed ID: 9813322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride.
    Levant B; Garimelli B; Shafer RA; Merchant KM
    Neuropsychopharmacology; 1999 Aug; 21(2):304-11. PubMed ID: 10432478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
    Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
    Gyertyán I; Sághy K
    Behav Pharmacol; 2004 Jul; 15(4):253-62. PubMed ID: 15252275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo occupancy of D2 dopamine receptors by nafadotride.
    Levant B; Vansell NR
    Neuropsychopharmacology; 1997 Aug; 17(2):67-71. PubMed ID: 9252981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C; Biala G; Le Bihan C; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2003 Feb; 166(1):19-32. PubMed ID: 12525958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement.
    Parsons LH; Caine SB; Sokoloff P; Schwartz JC; Koob GF; Weiss F
    J Neurochem; 1996 Sep; 67(3):1078-89. PubMed ID: 8752115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine.
    Richtand NM; Logue AD; Welge JA; Perdiue J; Tubbs LJ; Spitzer RH; Sethuraman G; Geracioti TD
    Brain Res; 2000 Jun; 867(1-2):239-42. PubMed ID: 10837819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
    Rogóz Z; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinjection of the preferential dopamine receptor D3 agonist 7-hydroxy-N,N-di-n-propylaminotetralin hydrobromide into the hypothalamic medial preoptic area induced ejaculation in anesthetized rats.
    Kitrey ND; Clément P; Bernabé J; Alexandre L; Giuliano F
    Neuroscience; 2007 Nov; 149(3):636-41. PubMed ID: 17916409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists.
    Kolasiewicz W; Maj J
    Pol J Pharmacol; 2001; 53(5):509-15. PubMed ID: 11990070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
    Barik S; de Beaurepaire R
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):718-26. PubMed ID: 15913875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo occupancy of D2 dopamine receptors by 7-OH-DPAT.
    Levant B; Bancroft GN; Selkirk CM
    Synapse; 1996 Sep; 24(1):60-4. PubMed ID: 9046077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.